The CSIR- Centre for Cellular and Molecular Biology has developed, possibly the first specific drug for COVID-19 treatment, which contain therapeutic antibodies.
About:
The Drug Controller General of India (DGCI) has given its approval for human trials, Phase-I and Phase-II for the VINCOV-19 and expected to be tried next week in Delhi and Rajasthan.
Developed by the CCMB, University of Hyderabad and Vins Bioproduct ltd combine, the VINCOV-19 is a collection of antibodies from Horses after they got injected inactivated Corona virus.
The approval for its emergency use by the India’s Drug Regulator is expected once the results of phase I and II declared.
VINCOV may be the first specific drug for COVID treatment and it works best when given on early stage of infection.
Dear Student,
You have still not entered your mailing address. Please enter the address where all the study materials will be sent to you. (If applicable).
